Gastrointestinal stromal tumours: origin and molecular oncology

CL Corless, CM Barnett, MC Heinrich - Nature Reviews Cancer, 2011 - nature.com
CL Corless, CM Barnett, MC Heinrich
Nature Reviews Cancer, 2011nature.com
Gastrointestinal stromal tumours (GISTs) are a paradigm for the development of
personalized treatment for cancer patients. The nearly simultaneous discovery of a
biomarker that is reflective of their origin and the presence of gain-of-function kinase
mutations in these tumours set the stage for more accurate diagnosis and the development
of kinase inhibitor therapy. Subsequent studies of genotype and phenotype have led to a
molecular classification of GIST and to treatment optimization on the basis of molecular …
Abstract
Gastrointestinal stromal tumours (GISTs) are a paradigm for the development of personalized treatment for cancer patients. The nearly simultaneous discovery of a biomarker that is reflective of their origin and the presence of gain-of-function kinase mutations in these tumours set the stage for more accurate diagnosis and the development of kinase inhibitor therapy. Subsequent studies of genotype and phenotype have led to a molecular classification of GIST and to treatment optimization on the basis of molecular subtype. The study of drug-resistant tumours has advanced our understanding of kinase biology, enabling the development of novel kinase inhibitors. Further improvements in GIST treatment may require targeting GIST stem cell populations and/or additional genomic events.
nature.com